UTHR Financial Facts

Diluted (in shares): 48.7M
Total operating expenses: 5.3M
See Full Income Statement

Other liabilities: 112.2M
Accumulated other comprehensive loss: -19.8M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 7/28/16 *Est. EPS Growth Rate +18.4% *Last Qtr.
Average EPS % Beat Rate +31.2% Revenue Growth Rate +12.6% *Last Qtr.
Average % Move 1-Wk after EPS +4.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/28/16 Q116 N/A$3.21 N/A $369M$397.42M N/A N/A N/A
2/25/16 Q415 $3.68$2.55 +$1.13$404.9M$388.29M N/A Details
10/27/15 Q315 $3.55$2.35 +$1.20$386.2M$363.5M N/A Details
7/28/15 Q215 $2.55$2.31 +$0.24$347.2M$360.41M N/A Details
4/28/15 Q115 $2.55$2.14 +$0.41$327.6M$353.5M N/A Details
2/24/15 Q414 $3.21$2.03 +$1.18$346.4M$336.22M N/A Details
10/28/14 Q314 $3.91$1.97 +$1.94$330M$335.1M N/A Details
7/29/14 Q214 $2.57$1.75 +$0.82$322.8M$308.04M N/A Details